Download video

Medicus Pharma begins phase 2 clinical trial in UAE for SkinJect cancer treatment

333 views

Proactive Investors

2 weeks ago

Medicus Pharma begins phase 2 clinical trial in UAE for SkinJect cancer treatment

Medicus Pharma begins phase 2 clinical trial in UAE for SkinJect cancer treatment

Alpha-2 Antiplasmin
7:04
Alpha-2 Antiplasmin
by Medicosis Perfectionalis
2025 International Symposium on Malignant Mesothelioma Day 2
2025 International Symposium on Malignant Mesothelioma Day 2
by Mesothelioma Applied Research Foundation
Simplify Dry Eye Management with I-MED Pharma’s Innovative B2B2C Program
0:39
Simplify Dry Eye Management with I-MED Pharma’s Innovative B2B2C Program
by I-MED Pharma
CHAPTER 2 - Improving surgical performance through human factors recognition \& enhanced team working
45:24
CHAPTER 2 - Improving surgical performance through human factors recognition \& enhanced team working
by MED_NESS
UW Medicine Pre-Transplant Pharmacist Education Part 2
11:13
UW Medicine Pre-Transplant Pharmacist Education Part 2
by UW Medicine
Obesity Part 2
16:58
Obesity Part 2
by Rx for Medication Education
Metylofenidat - lekarstwo na ADHD! Czy działa?
11:28
Metylofenidat - lekarstwo na ADHD! Czy działa?
by 9 volt NIRVANA
Bupron Dx tablet uses | Dextromethorphan Buprpion tablet
5:51
Bupron Dx tablet uses | Dextromethorphan Buprpion tablet
by LEARN ABOUT MEDICINE
All About Kyprolis (Carfilzomib)- A Proteasome Inhibitor for Multiple Myeloma (2025)
16:50
All About Kyprolis (Carfilzomib)- A Proteasome Inhibitor for Multiple Myeloma (2025)
by HealthTree University for Multiple Myeloma
Monoclonal Antibodies Drugs for Cancer
1:07
Monoclonal Antibodies Drugs for Cancer
by Drugs in Motion
Myeloma and Infections: What Medications Keep Patients Safe?
6:27
Myeloma and Infections: What Medications Keep Patients Safe?
by HealthTree University for Multiple Myeloma
The potential of MDM2 inhibitors in MPNs: past and ongoing studies of navtemadlin
9:54
The potential of MDM2 inhibitors in MPNs: past and ongoing studies of navtemadlin
by VJHemOnc – Video Journal of Hematology \& HemOnc
FDA Approves Truqap (capivasertib) + Faslodex for Patients with Advanced HR-Positive Breast Cancer
1:21
FDA Approves Truqap (capivasertib) + Faslodex for Patients with Advanced HR-Positive Breast Cancer
by Med-Chemist
Plans for Phase 2\/3 Clinical Trial of Bexmarilimab Plus SOC in Patients With MDS
5:16
Plans for Phase 2\/3 Clinical Trial of Bexmarilimab Plus SOC in Patients With MDS
by CheckRare
Patient-reported outcomes of mevrometostat and enzalutamide in mCRPC
1:52
Patient-reported outcomes of mevrometostat and enzalutamide in mCRPC
by VJOncology